Sequent Scientific gains on entering into pact to acquire 60% stake in Provet Veterinary Products

10 Sep 2014 Evaluate

Sequent Scientific is currently trading at Rs. 469.10, up by 11.35 points or 2.48 % from its previous closing of Rs. 457.75 on the BSE.

The scrip opened at Rs. 457.75 and has touched a high and low of Rs. 483.00 and Rs. 457.75 respectively. So far 19294 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 467.35 on 09-Sep-2014 and a 52 week low of Rs. 125.00 on 06-Dec-2013.

Last one week high and low of the scrip stood at Rs. 467.35 and Rs. 364.00 respectively. The current market cap of the company is Rs. 1287.49 crore.

The promoters holding in the company stood at 65.39 % while Institutions and Non-Institutions held 4.79 % and 29.82 % respectively.

Sequent Scientific’s wholly owned subsidiary, Alivira Animal Health (Alivira), has entered into an agreement to acquire 60% stake in Provet Veterinary Products, Turkey (Provet). The transaction is expected to close in October 2014, and is subject to customary closing conditions. The promoter of Provet is holding the balance 40% stake and will be part of the Management team at Alivira.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×